Evidence mapPaperPMID 25574244Full record

ArticleExperimental and therapeutic medicine2015

Effect of extractions from

Yanbo Fan, Jingjing Li, Qiang Yin, Yisheng Zhang, Huifang Xu, Xinhua Shi, Chen Li, Yan Zhou, Caixin Zhou

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Combination ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yanbo FanState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
Jingjing LiHubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.
Qiang YinHumanwell Healthcare Group Co., Ltd., Wuhan, Hubei 430000, P.R. China.
Yisheng ZhangState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
Huifang XuState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
Xinhua ShiState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
Chen LiState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
Yan ZhouState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
Caixin ZhouState Administration of Traditional Chinese Medicine of P.R.C (Level Three), Laboratory of Traditional Chinese Medicine Preparation, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, P.R. China.
State Administration of Traditional Chinese Medicine of the People's Republic of China · CNWuhan City Chinese Medicine Hospital · CNHubei University of Chinese Medicine · CNHumanwell Healthcare Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the hypolipidemic and antioxidant potential of ephedra extractions in diet-induced hyperlipidemic mice. Mice were fed a diet high in fat to establish the hyperlipidemic model. A total of 48 mice were randomly divided into six groups, which included the normal control, model control, positive control, ephedra alkaloid, ephedra polysaccharide and ephedra non-alkaloid groups. Intragastric administration of the respective treatments was provided continuously for four weeks and the body weight was recorded weekly. The total levels of cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and malondialdehyde (MDA), and the activity levels of superoxide dismutase (SOD), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum were recorded. In addition, changes in liver morphology and organ coefficients (ratio of organ to body weight) were evaluated, while the acute toxicity reactions of ephedra extractions were investigated using the modified Spearman-Karber method. Compared with the mice in the model control group, the weight, liver coefficient, serum levels of TC, TG and MDA, and activities of ALT and AST were significantly lower (P<0.05) in the mice in the ephedra non-alkaloid group. However, the level of HDL-C and the activity of SOD were markedly higher (P<0.05). Fatty degeneration of the liver in the ephedra alkaloid and non-alkaloid groups was notably improved compared with the model control group. The mean lethal dose (LD

Indexed as

acute toxicityephedra alkaloidsephedra non-alkaloidsephedra polysaccharideshyperlipidemia

Identifiers

PMID25574244
PMCPMC4280985
OpenAlexW1989170007

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.